Scion Life Sciences
Sam Hall is the Co-Founder & Managing Partner of Scion Life Sciences, a venture capital fund focusing on biotechnology companies dedicated to developing new medicines. Sam has also worked as a Director at Stoke Therapeutics, Chinook Therapeutics, Ascidian Therapeutics, Marengo Therapeutics, and Syntimmune. Additionally, Sam was a Partner at Apple Tree Partners and an Associate at Symphony Capital. Sam's educational background includes a degree in Molecular Biology from Princeton University, and MPhil and PhD degrees in Immunology from the University of Cambridge.
This person is not in any teams
Scion Life Sciences
Scion Life Sciences is a life sciences venture capital firm committed to meaningfully improving human health through long-term ownership of clinically transformative therapies. Our team of experienced innovators, company-builders and investors is founding and building exceptional biotechnology companies to discover, develop, and commercialize clinically transformational or curative new medicines. We aim to support impactful and sustainable advancements with a strategic and pragmatic approach to investment and innovation.